Momsense

Proven Economic Feasibility and Strategic Partnerships with Market Leaders

Momsense has proven its economic feasibility and has generated great demand for the product. The company has sold tens of thousands of units to date, as a pilot in Israel as a cooperation with the "Shilav Group" – Israel's largest baby-product chain, which was also among the first investors in the company, and with sales in the United States within the biggest retail stores TARGET, BABYSRUS and BUY BUY BABY, and to date the majority of the supply ran out, with only few hundreds of units available online. In addition, an agreement was recently signed with a strategic partner in China for the marketing of 10,000 additional units which are waiting for additional production to commence., and at this stage, negotiations are being held with a leading Israeli pharmaceutical company to distribute the product exclusively in Israel, and with a few European distributors.

Innovative, Patented Technology

Momsense has developed an innovative sensor-based technological solution to one of the most common fears among new mothers – a lack of confidence in knowing how much their baby has actually nursed. . The Smart Breastfeeding Meter is a simple and easy to use device that provides nursing mothers with real-time information and peace of mind, anywhere and anytime, with the goal of enhancing and prolonging the natural BF process. The company has two registered patents for its technology (patent approved and patent pending).

Worry that their baby is not getting enough milk is key reason mothers stop BF

Over 135M newborns are born worldwide each year. Breastfeeding (BF) rates of newborns are high, exceeding 80% in most developed countries. Yet, 50% of moms stop BF after 4-6 weeks! The reason: Worry that their baby is not getting enough milk is key reason mothers stop BF

A Huge Global Market

Momsense operates in the baby monitor market - a huge and growing market valued at tens of billions of dollars each year. The company's innovative development is unique in this market, as it is the first to provide a real solution to 135 million newborns and some 54 million nursing mothers a year - a number that has been growing steadily as global awareness of the importance of breastfeeding increases.

Approved for Marketing in the US and Europe

The company has CE approval for marketing its device in Europe and is authorized to market it in the United States without FDA approval who has confirmed the product to be a non-medical device, therefore it does not need to go through the regulatory processes). The product is completely safe to use and has passed all the most stringent safety testing. The sensor is connected to the baby by means of a hypoallergenic adhesive suitable to its sensitive skin. It is not invasive in any way and has no side effects.

Proven Economic Feasibility and Strategic Partnerships with Market Leaders

Momsense has proven its economic feasibility and has generated great demand for the product. The company has sold tens of thousands of units to date, as a pilot in Israel as a cooperation with the "Shilav Group" – Israel's largest baby-product chain, which was also among the first investors in the company, and with sales in the United States within the biggest retail stores TARGET, BABYSRUS and BUY BUY BABY, and to date the majority of the supply ran out, with only few hundreds of units available online. In addition, an agreement was recently signed with a strategic partner in China for the marketing of 10,000 additional units which are waiting for additional production to commence., and at this stage, negotiations are being held with a leading Israeli pharmaceutical company to distribute the product exclusively in Israel, and with a few European distributors.

The World's Largest Big-data Source for Infant Feeding Patterns

Momsense offers the “data” element behind the technology as well. Momsense sits on a data point where very little data is available (time of breastfeeds, length, quality, etc.) and is the first in the world to follow the eating patterns of many infants over time. This data is crucial for the baby-nutrition/formula companies, as well, for nursing mothers, for various reasons, often switch to other feeding choices.

Through more advanced assimilation of artificial intelligence (AI) and Machine learning (ML) analysis on breastfeeding, the company will be able to offer researchers, health professionals, Obstetrician-gynecologists and more, data that is not available to them anywhere else.

By creating a community of nursing mothers with common interests and needs, with access to an advanced log that will cover, among other things, the addition of bottle feeding and milk pump management, alerts and notification of doctor appointments, Vaccination or medication; monitoring of measurements such as head size, weight, and In particular, access to direct online counseling with professionals such as lactation consultants or pediatricians to address the distress or question of breastfeeding and the development of the baby.

All data collected can be used both for research and to offer complementary products or services.